Search results
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
The Motley Fool via AOL· 5 days agoAstraZeneca (NASDAQ: AZN) is embarking on a fresh business plan that will see it grow significantly between now and 2030. If it succeeds, it'll be a company that's even more ...
Astra's Enhertu breast cancer trial shows 'unprecedented' results
Reuters via AOL· 20 hours ago(Reuters) -AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters via AOL· 6 days agoAmgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex...
Compugen hits milestone with AstraZeneca cancer trial By Investing.com
Investing.com· 4 days agoThe trial is a crucial step in evaluating the drug as a first-line treatment for a specific type of...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 1 day agoBut what does June bring? Three Motley Fool contributors think the new month should usher in great investing opportunities. Here's why they picked AbbVie...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock | The Motley Fool
The Motley Fool· 5 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (PFE -1.70%) and AstraZeneca (AZN...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? | The Motley Fool
The Motley Fool· 5 days agoAstraZeneca (AZN -0.70%) is embarking on a fresh business plan that will see it grow significantly...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 10 hours agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Lifted by Hsbc Holdings PLC
ETF DAILY NEWS· 4 days agoHsbc Holdings PLC raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.7% during the fourth quarter, according to its most recent Form 13F filing with the ...
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com
Investing.com· 4 days agoOn Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a market...
